Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
Depreciation & Amortization
Valeo Pharma Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Valeo Pharma Inc
TSX:VPH
|
Depreciation & Amortization
-CA$656k
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
Bausch Health Companies Inc
TSX:BHC
|
Depreciation & Amortization
-$1.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
2%
|
|
Theratechnologies Inc
TSX:TH
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Depreciation & Amortization
-CA$45m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-90%
|
CAGR 10-Years
N/A
|
Spectral Medical Inc
TSX:EDT
|
Depreciation & Amortization
-CA$210k
|
CAGR 3-Years
11%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Depreciation & Amortization
-$1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-1%
|
See Also
What is Valeo Pharma Inc's Depreciation & Amortization?
Depreciation & Amortization
-656k
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Depreciation & Amortization amounts to -656k CAD.
What is Valeo Pharma Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-71%
Over the last year, the Depreciation & Amortization growth was -24%. The average annual Depreciation & Amortization growth rates for Valeo Pharma Inc have been -45% over the past three years , -71% over the past five years .